Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 287
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04578444 | An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer | ||
| NCT00710424 | A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy | ||
| NCT02544750 | An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) | ||
| NCT00780182 | Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers | ||
| NCT03134131 | Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline High Grade Gliomas | ||
| NCT01323569 | Abuse Potential of Sativex | ||
| NCT03865589 | Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome | ||
| NCT00875693 | A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML) | ||
| NCT06261502 | Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals with Fragile-X Syndrome | ||
| NCT04617002 | Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas | ||
| NCT05476939 | Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 | ||
| NCT04006925 | Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate | ||
| NCT04592159 | Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder | ||
| NCT02167685 | The Chimerix CMX001 Registry | ||
| NCT02087306 | Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection | ||
| NCT02533115 | EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML | ||
| NCT00670696 | A Study to Compare the Efficacy of Rapydan Versus Tetracaine Gel | ||
| NCT04794491 | An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy | ||
| NCT04133480 | Investigation of Cognitive Outcomes With Cannabidiol Oral Solution | ||
| NCT03929666 | A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer | ||
| NCT04530604 | Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS) | ||
| NCT01551524 | Phase I Study of mPEG-R-Crisantaspase Given IV | ||
| NCT01599234 | A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis | ||
| NCT05229588 | Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations | ||
| NCT05288283 | Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures | ||
| NCT00361842 | Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer | ||
| NCT05826756 | Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting | ||
| NCT02325011 | An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience. | ||
| NCT02954887 | Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7) | ||
| NCT07459634 | A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC | ||
| NCT05733390 | A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder | ||
| NCT03339401 | The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation | ||
| NCT00087555 | Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia | ||
| NCT05542407 | ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer | ||
| NCT07156435 | Vyxeos® With Clofarabine for Pediatric AML | ||
| NCT05009992 | Combination Therapy for the Treatment of Diffuse Midline Gliomas | ||
| NCT01401140 | Comparing the Protective Effects of Two Cardioplegic Solutions, on Cardiac Metabolism, as Assessed Using Microdialysis | ||
| NCT03526926 | A Post-Marketing Observational Study of VYXEOS™ | ||
| NCT04899947 | Child and Adolescent Registry for Participants With Narcolepsy | ||
| NCT03878927 | CPX-351+GO in Subjects 55 Years Old, or Older, With AML | ||
| NCT03849456 | Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder | ||
| NCT01886105 | Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma | ||
| NCT02221869 | A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy | ||
| NCT00710554 | A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia | ||
| NCT02091375 | Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) | ||
| NCT05244239 | Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer | ||
| NCT00066170 | Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy | ||
| NCT04447846 | Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome | ||
| NCT04984278 | Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis | ||
| NCT03533114 | A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension |
